Search research articles
Contact Us
Filters
Showing results (11-20 of 135) with videos related to
Page
of 14
Sort By:
Tumori
|
November 11, 2003
[ASCO 2003--What is changing in the treatment of colorectal cancer]
Flavia Longo, Giovanni Mansueto, Giuseppe Colucci
Journal of Thrombosis and Haemostasis : JTH
|
May 14, 2004
Effect of prolonged sitting on thrombin generation: not evidenced yet: reply to a rebuttal
Hans Stricker, Giuseppe Colucci, Giorgio Mombelli
International Journal of Molecular Sciences
|
July 27, 2022
Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
Mariapia Vairetti, Giuseppe Colucci, Andrea Ferrigno
Expert Opinion on Therapeutic Targets
|
March 27, 2012
The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer
Domenico Galetta, Antonio Rossi, Salvatore Pisconti, et al.
Expert Opinion on Therapeutic Targets
|
March 27, 2012
Metastatic melanoma: the new era of targeted therapy
Michele Guida, Salvatore Pisconti, Salvatore Pisconte, et al.
British Journal of Haematology
|
July 10, 2024
Plasma cells with Auer-rod-like inclusions in a patient with MGUS and acute myeloid leukaemia with NPM1 mutation
Janine Glanzmann, Christian Kalberer, Nicolas Bonadies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2011
Peripheral skin edema as unusual toxicity in three patients with advanced non-small cell lung cancer treated with pemetrexed alone or in combination with cisplatin
Domenico Galetta, Nicola Silvestris, Annamaria Catino, et al.
Clinical Chemistry and Laboratory Medicine
|
August 8, 2012
Effect of acceleration forces during transport through a pneumatic tube system on ROTEM® analysis
Gerhard Amann, Christine Zehntner, Florian Marti, et al.
Oncology
|
February 5, 2010
Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option?
Domenico Galetta, Antonio Rossi, Giuseppe Colucci, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2003
The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines
Jian-Ming Xu, Amalia Azzariti, Giuseppe Colucci, et al.
Page
of 14
Search research articles
Search
Showing results (11-20 of 135) with videos related to
Sort By:
Page
of 14
Tumori
|
November 11, 2003
[ASCO 2003--What is changing in the treatment of colorectal cancer]
Flavia Longo, Giovanni Mansueto, Giuseppe Colucci
Journal of Thrombosis and Haemostasis : JTH
|
May 14, 2004
Effect of prolonged sitting on thrombin generation: not evidenced yet: reply to a rebuttal
Hans Stricker, Giuseppe Colucci, Giorgio Mombelli
International Journal of Molecular Sciences
|
July 27, 2022
Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
Mariapia Vairetti, Giuseppe Colucci, Andrea Ferrigno
Expert Opinion on Therapeutic Targets
|
March 27, 2012
The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer
Domenico Galetta, Antonio Rossi, Salvatore Pisconti, et al.
Expert Opinion on Therapeutic Targets
|
March 27, 2012
Metastatic melanoma: the new era of targeted therapy
Michele Guida, Salvatore Pisconti, Salvatore Pisconte, et al.
British Journal of Haematology
|
July 10, 2024
Plasma cells with Auer-rod-like inclusions in a patient with MGUS and acute myeloid leukaemia with NPM1 mutation
Janine Glanzmann, Christian Kalberer, Nicolas Bonadies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
October 19, 2011
Peripheral skin edema as unusual toxicity in three patients with advanced non-small cell lung cancer treated with pemetrexed alone or in combination with cisplatin
Domenico Galetta, Nicola Silvestris, Annamaria Catino, et al.
Clinical Chemistry and Laboratory Medicine
|
August 8, 2012
Effect of acceleration forces during transport through a pneumatic tube system on ROTEM® analysis
Gerhard Amann, Christine Zehntner, Florian Marti, et al.
Oncology
|
February 5, 2010
Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option?
Domenico Galetta, Antonio Rossi, Giuseppe Colucci, et al.
Cancer Chemotherapy and Pharmacology
|
September 19, 2003
The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines
Jian-Ming Xu, Amalia Azzariti, Giuseppe Colucci, et al.
Page
of 14